As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

Journalist Saurabh Dwivedi's acting debut in Netflix's 'Kartavya' sparked online mockery, igniting a debate on India's culture of online ri...

The government is promoting decentralized development through clusters and simplifying business processes. Plans are underway to list 100 A...

As far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...

India faces a job creation challenge as millions enter the workforce. The nation needs to support entrepreneurship in key sectors like infr...

India's pharmaceutical industry has emerged as a formidable force on the world stage, contributing significantly to global health by produc...

An Indian pharmaceutical company, Kusum Healthcare, operating in Ukraine, suffered significant damages after a warehouse was reportedly str...

Pharma lobby group FOPE has requested the government to extend the compliance deadline for the revised Schedule M till December 31, 2026. T...

In a recent diktat, the government said action will be taken against pharma units that are flouting the norms by manufacturing nutraceutica...

The Covid-19 pandemic seemed to have helped in enhancing the wealth of a few players. In particular, Cyrus Poonawalla’s wealth surged by on...

In the textile sector, competition is growing tremendously, but a lot of Indian entrepreneurs are entering into the field and they are stil...

ChrysCapital said it was backing a combination of a great management team, strong brands and superior marketing capabilities in the fast gr...

The 'Innovate in India empowering biotech entrepreneurs and accelerating inclusive innovation' mission will strengthen domain specific know...

Terming the decision to ban 344 fixed dose combination medicines as "arbitrary and unfair", pharma industry has said it feels let down by t...

Pankaj Ramanbhai Patel, chairman and managing director of the pharmaceutical giant Zydus Cadila, has been appointed chairman of IIM Udaipur.

Lupin is now a big pharma player in the US both in generics and brands, thanks to Vinita Gupta's entrepreneurial drive.

India is a favourite clinical trials destination. The CRO business grew 84% during 2006-2008 as against the global average of 12%.